All Stories

  1. Microalbuminuria on admission for acute exacerbation of COPD as a predictor of all-cause mortality and future exacerbations
  2. Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study
  3. Tocilizumab administration for the treatment of hospitalized patients with COVID ‐19: A systematic review and meta‐analysis
  4. Late Breaking Abstract - Tocilizumab administration for the treatment of hospitalised patients with COVID-19: A systematic review and meta-analysis
  5. Biomarkers model for prediction of hospitalisation duration and pulmonary embolism outcome
  6. Prothrombotic state in patients with stable COPD: an observational study
  7. Hypercoagulable State in COPD-A Comprehensive Literature Review
  8. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study
  9. Achievement of High Quality Home Spirometry in Patients with Asthma: The NuvoAir Platform
  10. Reduction in Hospitalizations for Respiratory Diseases during the First COVID-19 Wave in Greece
  11. Endothelial injury in Chronic Obstructive Pulmonary Disease assessed by microalbuminuria (MAB) and von Willebrand factor levels and activity
  12. The role of microalbuminuria (MAB) in patients admitted for an Acute COPD Exacerbation (AECOPD)
  13. Hypercoagulability in patients with stable COPD assessed by coagulation factor levels
  14. A 68-year-old man with haemoptysis and extensive ipsilateral lung infiltrates
  15. Corticosteroids in COVID-19: one size does not fit all
  16. A direct adverse effect of smoking
  17. Legionella pneumonia presenting with reverse halo sign
  18. Identification and treatment of T2-low asthma in the era of biologics
  19. Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac)
  20. Hypercoagulability in patients with stable COPD assessed by coagulation factor levels
  21. Primary Pulmonary Malignant Melanoma: Report of an Important Entity and Literature Review